Gossamer Bio Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$480M
Industry:Biotech
Founded:2017
Lead Investor(s):Hillhouse Capital
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Revenue & Financials

  • Gossamer Bio's revenue is currently $6M per year.
  • Gossamer Bio received $230.0M in venture funding in July 2018.
  • Gossamer Bio's revenue per employee is $53496
  • Gossamer Bio's total funding is $480M.

Employee Data

  • Gossamer Bio has 113 Employees.
  • Gossamer Bio grew their employee count by 190% last year.
  • Gossamer Bio currently has 12 job openings.

What Is Gossamer Bio?

Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio's strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.

keywords:N/A

113

Number of Employees

$6M

Revenue (est)

12

Current Jobs

190%

Employee Growth %

$480M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Mission Bio
$7.4M6944%
Rigel Pharmaceu...
$40.5M2714%
ProTrials Resea...
$25.6M1703%
Advanced Cell D...
$23.9M1668%
CellMax Life
$10M379%$9M
Atreca
$10.7M8117%
Full Spectrum A...
$5.7M395%
Pipette.com/Acc...
N/AN/A
Irvine Scientif...
$29.1M2059%
Talis Biomedica...
$8.1M544%

Gossamer Bio News

20-Mar-19 - There Is Enough Gas Left In The Tank: Gossamer Bio, Inc. (GOSS), EP

Gossamer Bio, Inc. (NASDAQ:GOSS) recently ticked higher on weak volume. About 226421 contracts were traded on 18-Mar-19 compared to

20-Mar-19 - Gossamer Bio (GOSS) Shares Gap Up to $20.48

Gossamer Bio Inc (NASDAQ:GOSS) shares gapped up before the market opened on Monday . The stock had previously closed at $20.46, but

20-Mar-19 - Gossamer Bio (GOSS) stock price is worth at $22.09

Volatility Insights. Watching some historical volatility numbers on shares of Gossamer Bio (GOSS) we can see that the 30 days volatility is

Gossamer Bio Funding

DateAmountRoundLead InvestorsReference
2018-01-08$100.0MUndisclosedOmega FundsArticle
2018-07-24$230.0MHillhouse CapitalArticle

Gossamer Bio Executive Hires

DateNameTitleReference
2018-07-24Sheila GujrathiChief Executive Officer, and Co-FounderArticle
2018-09-06Luisa Salter-CidChief Scientific OfficerArticle
2018-12-18Jakob DupontChief Medical OfficerArticle